Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1120 (LINC01120) is a gene that encodes a long intergenic non-coding RNA (lincRNA), a subtype of long non-coding RNAs (lncRNAs) that does not overlap with protein-coding genes and is longer than 200 nucleotides. LINC01120 is classified as a non-coding RNA and, as such, does not code for any protein product. As of the most recent data, no specific molecular function, biological process, or disease association has been described for LINC01120 in the literature or major biological databases. LincRNAs like LINC01120 generally participate in the regulation of gene expression and chromatin organization, but detailed experimental validation is lacking for this individual lincRNA. No drug interactions or biomarker use are reported, and it is not considered a validated therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1120 (LINC01120).